Ligand Pharmaceuticals LGND

$

9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
.
9
8
7
6
5
4
3
2
1
0
0
+$2.74 (+2.71%)Past DayToday's Volume:
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
,
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0

Relative Strength Index (RSI)

- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.

- The RSI is calculated using the following formula:

RSI = 100 - (100 / (1 + RS))

Where RS is the ratio of the average gains to the average losses over a specified period.

- The default time period used is 14 days.

- RSI values range between 0 and 100.

RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)

RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)

RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.

Key Insights

Ligand Pharmaceuticals (LGND) Core Market Data and Business Metrics
  • Latest Closing Price

    $101.29
  • Total Outstanding Shares

    19.26 Million Shares
  • Dividend

    No dividend
  • SIC Description

    Pharmaceutical Preparations
  • Primary Exchange

    NASDAQ
  • Headquarters

    3911 Sorrento Valley Blvd, San Diego, CA, 92121

Historical Stock Splits

Execution DateSplit Amount

Short Interest

Short Interest

This information is bi-monthly aggregated short interest data reported to the Financial Industry Regulatory Authority (FINRA) by broker-dealers.

Short Interest: The total number of shares that have been sold short but have not yet been covered or closed out.

Settlement Date: The date on which the short interest data is considered settled, typically based on exchange reporting schedules.

Bi-Weekly Change (%): The percentage change in short interest from the previous bi-weekly period.

Track Short Interest Levels to Gauge Bearish Market Sentiment and Short Squeeze Potential
Short InterestSettlement DateBi-Weekly Change (%)
1.01 Million Shares3/31/2025+5.61%
955.11 Thousand Shares3/14/2025+22.44%
780.08 Thousand Shares2/28/2025-7.68%
844.95 Thousand Shares2/14/2025-11.20%
951.52 Thousand Shares1/31/2025+4.40%
911.39 Thousand Shares1/15/2025+1.25%

Historical Dividends

Announcement DatePayment DateRecord DateAmountFrequency
No historical dividends

Recent Headlines From The Web

Latest news, press releases, and media coverage about LGND from trusted financial sources

    Related Companies

    Publicly traded companies similar to Ligand Pharmaceuticals (LGND)